Although 6SL did not inhibit prostatic cell growth, pRB/E2F1–AR protein expression was significantly inhibited, supporting the non-cytotoxic but specific inhibitory effects of 6SL on the pathological or abnormal expression of BPH-related genes. Here, E2F1 is linked to benign prostatic hyperplasia.